|
Marché Fermé -
17:24:29 02/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
10,35 USD
|
+1,47%
|
 |
+1,47%
|
-23,26%
|
|
27/04 |
Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates
| | |
26/03 |
Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.
| | |
23/03 |
Motion for Asset Sale Filed by Finch Therapeutics Group, Inc.
| | |
22/03 |
Motion for Joint Administration Filed by Finch Therapeutics Group, Inc.
| | |
22/03 |
Finch Therapeutics Group, Inc. Filed for Bankruptcy
| | |
08/12 |
Pepgen Inc. Appoints Joseph Vittiglio as Chief Business and Legal Officer, Effective December 8, 2025
| | |
21/10/24 |
Finch Announces Delisting from Nasdaq and SEC Deregistration
| | |
15/08/24 |
Ferring v Finch: Ripples From The Decision
| | |
13/08/24 |
Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
| | |
30/05/24 |
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from S&P TMI Index
| | |
27/05/24 |
Finch Therapeutics Group, Inc.(OTCPK:FNCH) dropped from NASDAQ Composite Index
| | |
10/05/24 |
Finch Therapeutics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
25/03/24 |
Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
| | |
25/03/24 |
Finch Therapeutics Group, Inc. Auditor Raises 'Going Concern' Doubt
| | |
12/03/24 |
Top Premarket Decliners
| | |
08/11/23 |
Finch Therapeutics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
| | |
27/10/23 |
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
| | |
10/08/23 |
Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
| | |
23/06/23 |
Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board
| | |
23/06/23 |
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Index
| | |
23/06/23 |
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Value Index
| | |
23/06/23 |
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Value Index
| | |
23/06/23 |
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Index
| | |
13/06/23 |
Top Premarket Decliners
| | |
13/06/23 |
Finch Therapeutics Group Slumps Almost 15% in Premarket Tuesday
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
